The Conquer Cancer Foundation of ASCO (CCF) presented more than $6.1 million in grants and awards to nearly 250 promising oncology researchers at the 2016 ASCO Annual Meeting. The Conquer Cancer Foundation and ASCO congratulate the recipients on their contributions to the field of oncology and offer their profound thanks to the generous organizations that supported these awards.
To see the complete list, visit
Advanced Clinical Research Award in Breast Cancer
The Advanced Clinical Research Award (ACRA) funds investigators in their 4th–9th year of faculty appointment who are committed to clinical cancer research in an area not currently funded. The award is supported by the Breast Cancer Research Foundation®탎.
Carey Anders, MD, Advanced Clinical Research Award in Breast Cancer recipient, with CCF Board of Directors Chair Thomas G. Roberts Jr, MD.
Career Development Awards
The Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. This year’s recipients will each receive a 3-year grant totaling $200,000.
Career Development Awards recipients: Matthew Hellmann, MD; Renata Ferrarotto, MD; Aki Morikawa, MD, PhD; Neil Iyengar, MD; Solmaz Sahebjam, MD; Alice Fan, MD; Michael Postow, MD; and Quoc-Dien Trinh, MD. Not pictured: Gabriel Brooks, MD, MPH, and Eli Diamond, MD.
CDAs are supported by the Adenoid Cystic Carcinoma Research Foundation; Amgen; Astellas; AstraZeneca; Breast Cancer Research Foundation; Genentech BioOncology; Janssen Scientific Affairs, LLC; Lilly; Michael’s Mission; Roche; Takeda Oncology; and the Triple Negative Breast Cancer Foundation.
Young Investigator Awards
The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. This year’s 58 awardees will each receive a 1-year grant of $50,000.
YIAs are supported by Anonymous; AbbVie, Inc; American Association for Cancer Research; ASCO; Amgen; ASCO and Conquer Cancer Foundation Boards of Directors; ASCO State Affiliate Council and ASCO Clinical Practice Committee; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Breast Cancer Research Foundation; Celgene Corporation; The Cholangiocarcinoma Foundation; Conquer Cancer Foundation; Conquer Cancer Foundation Women Who Conquer Cancer; Eisai Inc.; EMD Serono Inc.; Ethicon; Fibrolamellar Cancer Foundation; Florida Society of Clinical Oncology; Gateway for Cancer Research; Genentech BioOncology; Gilead Sciences, Inc.; HELSINN; Incyte Corporation; Janssen Oncology; Janssen Scientific Affairs, LLC; the Journal of Clinical Oncology; Kidney Cancer Association; The John and Elizabeth Leonard Family Foundation; Lilly; Lung Cancer Alliance; J. Edward Mahoney Foundation; Merck & Co., Inc.; Novartis Oncology; Susan K. Parsons, MD, and Walter Armstrong; Pfizer Oncology; The Reid R. Sacco Adolescent and Young Adult Cancer Alliance; Aaron and Barbro Sasson; Strike 3 Foundation; Takeda Oncology; Triple Negative Breast Cancer Foundation; and The WWWW Foundation, Inc. (QuadW) and The Sarcoma Fund of the QuadW Foundation of Communities Foundation of Texas.
The International Development and Education Award (IDEA) and IDEA-Palliative Care (IDEA-PC) recipients. Back row: Fábio de Figueirêdo Chaves, MD; Manuel Caitano Maia, MD; Raja Pramanik, MD; Davit Zohrabyan, MD; Uday Yanamandra, MBBS, MD; Jayson L. Co, MD; Jesse Elungat Opakas, MBBS, MD; Pham Tuan Anh, MD; Fernando Pérez Jacobo, MD; and Andre Jerome Williams, MBBS, DM. Front row: Juliano Cé Coelho, MD; Kul Ranjan Singh, MBBS, MS, MCh; Jalil Salih Ali, MBChB; Yusuf Adetomiwa Adelabu, MBBS; Sandhya Chapagain Acharya, MD; Susmita Sharma, MBBS, MD; Narmin Talibova, MD; Andrea Craciunescu, MD; Chris Tania Echeveste, MD, PhD; Ali Alkan, MD; Dorothy Chilambe Lombe, MD; and Oladapo Adedayo Kolawole, MBBS. Not pictured: Mohammed Abdulqader Suwaid, MBChB, MD.
International Development and Education Award
The International Development and Education Award (IDEA) and IDEA-Palliative Care (IDEA-PC) provide support for early-career oncologists in low- and middle-income countries to further their knowledge and careers and establish strong long-term relationships with leading ASCO members who serve as scientific mentors. This year’s 20 IDEA and 3 IDEA-PC awardees attended the 2016 ASCO Annual Meeting and visited their mentor’s institution, where they gained knowledge and skills to share with their peers back home.
IDEAs are supported by Avon Foundation for Women; Bayer HealthCare Pharmaceuticals Inc.; Conquer Cancer Foundation Mission Endowment; CRDF Global; National Cancer Institute; National Science Foundation; NF Nimeh, MD; and Takeda Oncology.
Medical Student Rotation for Underrepresented Populations
The Medical Student Rotation (MSR) for Underrepresented Populations provides 8- to 10-week clinical or clinical research oncology rotations for U.S. medical students from populations underrepresented in medicine who are interested in pursuing oncology as a career. This year, five medical students were selected:
The MSR for Underrepresented Populations is supported by Amgen; Conquer Cancer Foundation; Janssen Oncology; and Lilly.
Resident Travel Award for Underrepresented Populations
Resident Travel Award for Underrepresented Populations recipients: Lionel Aurelien Kankeu Fonkoua, MD; Carolina Soto Chervin, MD, PhD; Kimberley Lee, MD; Leslie S. Anewenah, MD; Frederick Edem Doamekpor, MD; Ashley Cheree Woods, MD; Chinelo Madubom, MBBS; Fiyinfolu Balogun, MD, PhD; and Sherise C. Rogers, MD, MPH. Not pictured: Lina Maria Ortega, MD.
The Resident Travel Award (RTA) for Underrepresented Populations provides financial support for residents from underrepresented populations to attend the ASCO Annual Meeting. This year, 10 residents were selected:
The RTA is supported by Amgen; Conquer Cancer Foundation Mission Endowment; and Janssen Oncology.
Clinical Trials Participation Award
The Clinical Trials Participation Award (CTPA) recognizes and promotes high-quality clinical research sites with the intent to increase the awareness of and participation in clinical trials among physicians. The awards are presented to community-based practices participating in clinical trials at an exceptional level. The Coalition of Cancer Cooperative Groups has supported these awards for 14 consecutive years. Three practices were honored this year:
Merit Awards for High-Quality Research
Special Merit Award recipients: Ian Kleckner, PhD; Nickhill Bhakta, MD, MPH; Mark W. Knestrick Jr., MD, PharmD; and Alvaro Lassaletta, MD. Not pictured: Raja Pramanik, MD.
The Conquer Cancer Foundation distributed 102 Merit Awards to oncology fellows who submitted high-quality research for presentation at the 2016 ASCO Annual Meeting and 5 Special Merit Awards for the highest-ranking abstracts in select categories. The 2016 Special Merit Award recipients are:
The 2016 Merit Awards are supported by Amgen; AstraZeneca; friends, family, and colleagues of Dr. Ronald Beller, Mrs. Judith Beller, and Dr. James B. Nachman; Celgene Corporation; Conquer Cancer Foundation; Gilead Sciences, Inc.; Janssen Oncology; Kidney Cancer Association; Lilly; Novartis Oncology; Jackson G. Simpson; Spectrum Pharmaceuticals; and Takeda Oncology.
Oncology Trainee Travel Awards
The Oncology Trainee Travel Award (OTTA) supports the continuing education and professional development of trainee oncologists by providing individual travel grants to defray travel expenses for attending the ASCO Annual Meeting. In 2016, the Conquer Cancer Foundation awarded 28 OTTAs.
OTTAs are supported by Amgen and Takeda Oncology.
2016 Long-Term International Fellowship
Long-term International Fellowship recipients: Enrique Soto Perez de Celis, MD; Shuhang Wang, MD, MS; Allan Andresson Lima Pereira, MD, PhD; and Nisreen Yousef Amayiri, MBBS, MD.
The Long-term International Fellowship (LIFe) provides early-career oncologists in low- to middle-income countries the support and resources needed to advance their training by deepening their relationship with a mentor from the United States, Canada, or Europe and their institution. This year’s recipients are:
The LIFe is supported by Amgen; Conquer Cancer Foundation; Conquer Cancer Foundation Mission Endowment; and Roche. ■
All recipient lists are up-to-date as of June 8, 2016.
Originally printed in the July issue of ASCO Connection. © American Society of Clinical Oncology. “ASCO, Conquer Cancer Foundation Congratulate 2016 Grant and Award Recipients.” All rights reserved.